BRPI0507545A - composições e métodos para o tratamento e remissão clìnica de psorìase - Google Patents
composições e métodos para o tratamento e remissão clìnica de psorìaseInfo
- Publication number
- BRPI0507545A BRPI0507545A BRPI0507545-9A BRPI0507545A BRPI0507545A BR PI0507545 A BRPI0507545 A BR PI0507545A BR PI0507545 A BRPI0507545 A BR PI0507545A BR PI0507545 A BRPI0507545 A BR PI0507545A
- Authority
- BR
- Brazil
- Prior art keywords
- psoriasis
- treatment
- compositions
- methods
- clinical remission
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
COMPOSIçÈES E MéTODOS PARA O TRATAMENTO E REMISSãO CLìNICA DE PSORìASE Um tratamento para psoríase e malgnidades relacionadas tem um mecanismo de ação que inclui uma inibição ou bloqueio de rolamento de células T através de interferência na interação CLA/E-selectina e interferência na ligação endotelial ou diapedese induzida através de bloqueio da interação LFA-1/ICAM e/ou da interação VLA/VCAM com células endoteliais.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/774,928 US20040241168A1 (en) | 2001-03-16 | 2004-02-09 | Compositions and methods for the treatment and clinical remission of psoriasis |
PCT/US2005/003994 WO2005084444A1 (en) | 2004-02-09 | 2005-02-08 | Compositions and methods for the treatment and clinical remission of psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0507545A true BRPI0507545A (pt) | 2007-07-03 |
Family
ID=34919679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0507545-9A BRPI0507545A (pt) | 2004-02-09 | 2005-02-08 | composições e métodos para o tratamento e remissão clìnica de psorìase |
Country Status (8)
Country | Link |
---|---|
US (1) | US20040241168A1 (pt) |
EP (1) | EP1720410A4 (pt) |
JP (1) | JP2007522221A (pt) |
AU (1) | AU2005220149A1 (pt) |
BR (1) | BRPI0507545A (pt) |
CA (1) | CA2555612A1 (pt) |
MX (1) | MXPA06009076A (pt) |
WO (1) | WO2005084444A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040241168A1 (en) * | 2001-03-16 | 2004-12-02 | O'daly Jose A. | Compositions and methods for the treatment and clinical remission of psoriasis |
WO2008131301A1 (en) * | 2007-04-18 | 2008-10-30 | Massachusetts Institute Of Technology | Surfaces, methods and devices employing cell rolling |
CN101918543A (zh) | 2007-09-27 | 2010-12-15 | 麻省理工学院 | 细胞滚动分离 |
US20140356391A1 (en) * | 2013-05-29 | 2014-12-04 | Jose Antonio O'Daly | Amino acid sequences for clinical remission of psoriasis and related diseases. |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3581288D1 (de) * | 1984-10-01 | 1991-02-14 | Pasteur Institut | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. |
US4687666A (en) * | 1985-02-19 | 1987-08-18 | Ministerio De Sanidad Y Asistencia Social Instituto Venezolano De Investigationes Cientificas | Vaccine for Leishmaniasis |
US5726292A (en) * | 1987-06-23 | 1998-03-10 | Lowell; George H. | Immuno-potentiating systems for preparation of immunogenic materials |
US5202320A (en) * | 1989-04-06 | 1993-04-13 | Tidwell Richard R | Method for treating leishmaniasis |
US5674503A (en) * | 1990-07-24 | 1997-10-07 | University Of Victoria | Peptides capable of eliciting an immune response to leishmaniasis and methods of using the same |
FR2682107B1 (fr) * | 1991-10-03 | 1995-04-21 | Orstom Inst Fs Rech Scient | Quinoleines 2-substituees pour le traitement des leishmanioses. |
US5411865A (en) * | 1993-01-15 | 1995-05-02 | Iasys Corporation | Method of detecting anti-leishmania parasite antibodies |
WO1995006729A1 (en) * | 1993-09-03 | 1995-03-09 | Mcgill University | Differentially expressed leishmania genes and proteins |
US5961979A (en) * | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
US5571515A (en) * | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
US6013268A (en) * | 1994-04-22 | 2000-01-11 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5876735A (en) * | 1994-04-22 | 1999-03-02 | Corixa Corporation | Methods for enhancement of protective immune responses |
WO1995029699A1 (en) * | 1994-04-29 | 1995-11-09 | Curtis Powell | Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa |
US6174995B1 (en) * | 1994-08-23 | 2001-01-16 | Haodong Li | Human chemokines, CKβ4 and CKβ10/MCP-4 |
US5496830A (en) * | 1994-09-14 | 1996-03-05 | Johns Hopkins University | Inhibition of hemoflagellates by camptothecin compounds |
US5674748A (en) * | 1995-03-14 | 1997-10-07 | Thomas Jefferson University | Human cyclin-dependent kinase-like proteins and methods of using the same |
US5912166A (en) * | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
US5928928A (en) * | 1995-06-07 | 1999-07-27 | Universiteit Van Amsterdam | Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
US5965142A (en) * | 1995-08-04 | 1999-10-12 | Corixa Corporation | Polypeptides and methods for the detection of L. tropica infection |
US5834592A (en) * | 1995-09-22 | 1998-11-10 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
US5767097A (en) * | 1996-01-23 | 1998-06-16 | Icn Pharmaceuticals, Inc. | Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
US6162638A (en) * | 1996-05-06 | 2000-12-19 | Universite Laval | Attenuated strains of leishmania and uses thereof |
US5952194A (en) * | 1996-08-01 | 1999-09-14 | Heska Corporation | Flea nucleic acid sequences and uses thereof |
WO1998043656A1 (en) * | 1997-04-02 | 1998-10-08 | Bioniche Inc. | Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease |
US5854051A (en) * | 1997-09-15 | 1998-12-29 | Heska Corporation | Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof |
US6087341A (en) * | 1998-02-12 | 2000-07-11 | The Board Of Trustees Of The Leland Standford Junior University | Introduction of nucleic acid into skin cells by topical application |
US6568952B1 (en) * | 2000-08-02 | 2003-05-27 | Swenco Products, Inc. | T-tap connector |
US20040241168A1 (en) * | 2001-03-16 | 2004-12-02 | O'daly Jose A. | Compositions and methods for the treatment and clinical remission of psoriasis |
US6673351B1 (en) * | 2001-03-16 | 2004-01-06 | Astralis, Llc | Compositions and methods for the treatment and clinical remission of psoriasis |
-
2004
- 2004-02-09 US US10/774,928 patent/US20040241168A1/en not_active Abandoned
-
2005
- 2005-02-08 AU AU2005220149A patent/AU2005220149A1/en not_active Abandoned
- 2005-02-08 EP EP05713139A patent/EP1720410A4/en not_active Withdrawn
- 2005-02-08 WO PCT/US2005/003994 patent/WO2005084444A1/en active Application Filing
- 2005-02-08 MX MXPA06009076A patent/MXPA06009076A/es not_active Application Discontinuation
- 2005-02-08 BR BRPI0507545-9A patent/BRPI0507545A/pt not_active Application Discontinuation
- 2005-02-08 CA CA002555612A patent/CA2555612A1/en not_active Abandoned
- 2005-02-08 JP JP2006553191A patent/JP2007522221A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MXPA06009076A (es) | 2007-03-08 |
WO2005084444A1 (en) | 2005-09-15 |
EP1720410A4 (en) | 2008-07-02 |
CA2555612A1 (en) | 2005-09-15 |
US20040241168A1 (en) | 2004-12-02 |
JP2007522221A (ja) | 2007-08-09 |
AU2005220149A1 (en) | 2005-09-15 |
EP1720410A1 (en) | 2006-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0818437B8 (pt) | anticorpo ou fragmento funcional do anticorpo, composição farmacêutica, uso de pelo menos um dos anticorpos ou fragmentos funcionais dos anticorpos, e, hibridoma | |
BR112012009262A2 (pt) | ''método para inibir a proliferação de células de câncer positivo para ar em um indivíduo diagnosticado com,ou qual se suspeita que tenha cânce positivo para ar e método para identificar se um indivíduo é um candidato para tratamento com uma composiçâo | |
BRPI0516727A (pt) | métodos para tratar um linfoma positivo em cd30 , para inibir o crescimento de uma célula que expressa cd30, e para tratar ou prevenir uma doença | |
CL2008001656A1 (es) | Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene. | |
ATE323501T1 (de) | Pharmazeutische zusammensetzung enthaltend proteoglykan und ihre verwendung zur behandlung von entzündlichen erkrankungen | |
BRPI0721503A8 (pt) | composições e métodos para tratamento de um poço bloqueado por água | |
BR0012595A (pt) | Ligação de fonte de dados de célula em folha de desenvolvimento | |
ATE510242T1 (de) | Ablagerungsminderungssystem mit verbesserter gasverteilung | |
WO2008103470A3 (en) | Oncogenic-ras-signal dependent lethal compounds | |
BRPI0618577A8 (pt) | Usos de rituximab | |
MX349137B (es) | Metodos y composiciones para el tratamiento de infecciones persistentes y cancer por inhibicion de la ruta de muerte celular programada (pd-1). | |
MX2011006091A (es) | Inhibidores de imidazopirazina syk. | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
BR112012031612A2 (pt) | montagem de caixa para dejetos dotada de um dispositivo de fragmentação de granulado sanitário | |
WO2007143211A3 (en) | Methods for identifying agents and their use for the prevention of restenosis | |
BRPI0821003B8 (pt) | método para aumentar a imunorreatividade | |
BRPI0507545A (pt) | composições e métodos para o tratamento e remissão clìnica de psorìase | |
BRPI0607504A2 (pt) | população de suìnos que possui baixos nìveis de retrovìrus endógenos suìnos e usos dos mesmos | |
AR066527A1 (es) | Panel para la contruccion de edificios con salientes perpendiculares a una cara | |
BRPI0612424A2 (pt) | composiÇÕes e mÉtodos para tratar condiÇÕes relacionadas com a sinalizaÇço da efrina com cupredoxinas | |
BRMU8602727U (pt) | disposição construtiva introduzida em tampa | |
BRPI0716397A2 (pt) | mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero. | |
CL2008003799A1 (es) | Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis. | |
CR9853A (es) | Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion | |
BRPI0810762A8 (pt) | Composição para tratamento da água |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |